Precision medicine and actionable alterations in lung cancer: A single institution experience.
Isa MambetsarievYingyu WangChen ChenSorena NadafRebecca R PharaonJeremy FrickeIdoroenyi AmanamArya AminiAndrea BildPeiguo ChuLoretta ErhunmwunseeJae KimJanet MunuRaju PillaiDan RazSagus SampathLalit VoraFang QiuLynette SmithSurinder K BatraErminia MassarelliMarianna KoczywasKaren ReckampRavi SalgiaPublished in: PloS one (2020)
The use of patient registries, focused genomic panels and the appropriate use of clinical guidelines in community and academic settings may influence cohort selection for clinical trials and improve survival outcomes.